BeOne Medicines AG ONC
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 10.43% | 12.94% | |||
| Total Other Revenue | 37.51% | -3.19% | |||
| Total Revenue | 10.83% | 12.66% | |||
| Cost of Revenue | 24.27% | 4.37% | |||
| Gross Profit | 9.30% | 13.69% | |||
| SG&A Expenses | 0.04% | 6.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.60% | 9.22% | |||
| Operating Income | 28.80% | 30.07% | |||
| Income Before Tax | 31.33% | 20.54% | |||
| Income Tax Expenses | -66.00% | 136.84% | |||
| Earnings from Continuing Operations | 62.32% | 4.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 62.32% | 4.24% | |||
| EBIT | 28.80% | 30.07% | |||
| EBITDA | 25.29% | 25.81% | |||
| EPS Basic | 59.29% | 3.67% | |||
| Normalized Basic EPS | 30.18% | 18.67% | |||
| EPS Diluted | 56.25% | 6.67% | |||
| Normalized Diluted EPS | 30.95% | 19.31% | |||
| Average Basic Shares Outstanding | 1.90% | 0.56% | |||
| Average Diluted Shares Outstanding | 1.30% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||